Tetsuhiro Miyake

Nomura Asset Management Co., Ltd. (NAM) is the wholly-owned investment management subsidiary of Nomura Holdings, Inc. (TYO: 8604; NYSE: NMR) in Japan. Founded in 1959 as Nomura Securities Investment Trust Co., Ltd., the firm became Nomura Asset Management Co., Ltd. in 1997 when they merged with Nomura Investment Management Co., Ltd. Headquartered in Tokyo, NAM provides investment advisory services globally to a broad range of institutional investors as well as pooled investment vehicles, including private funds and Japanese investment trusts.

Nomura Securities Co., Ltd. (NSC) is a wholly-owned brokerage subsidiary of Nomura Holdings, Inc. (TSE: 8604; NYSE: NMR). Headquartered in Tokyo, the firm was founded in 1925. NSC places a strong emphasis on research, both fundamental and quantitative. In addition to stock and bond underwriting, their activities include IPO and M&A advisory, wealth management, separately managed accounts, fund wrap services, prime brokerage and structured equity finance. Their clients include institutions, hedge funds, private banks and private equity funds as well as corporate clients and retail investors.

LOTTE Co., Ltd. manufactures and markets sweets, confectioneries, and desserts such as chewing gums, chocolates, candies, biscuits, cookies, and ice cream. It also engages in the business of real estate operations, golf course operations, and hotel and restaurant management services. The company was founded by Kyuk-Ho Shin in June 1948 and is headquartered in Tokyo, Japan.

Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products.

Part of Unison Capital, Inc., I'rom Pharmaceutical Co., Ltd. is a pharmaceutical company based in Tokyo, Japan. I'rom Pharmaceutical Co. manufactures and markets pharmaceuticals. I'rom Pharmaceutical Co. was acquired by Kyowa Pharmaceutical Industry Co., Ltd., a SUB of Unison Capital, Inc. from I'rom Group Co., Ltd. on November 30, 2011 for $40.28 million.